interferon alpha (HanAll)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameinterferon alpha (HanAll)
Drug Alias NameBelerofon (Nautilus/HanAll)IFN alpha (Nautilus/HanAll)interferon alpha (Nautilus/HanAll)HL-031
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterferon alpha ligand
TargetsInterferon alpha
Therapy Area/IndicationsMelanomaHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFranceSouth Korea
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNautilus Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNautilus BiotechHanAll Biopharma Co Ltd
Active IndicationsN/A
Inactive IndicationsMelanomaHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A